Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

4 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4

3(75.0%)

Phase 3

1(25.0%)

4Total

Phase 4(3)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT01997242Completed

The Surgery After Stenting (SAS) Registry

Role: collaborator

NCT01777503Phase 4Completed

The Elderly ACS II Trial

Role: collaborator

NCT03392948Unknown

PERcutaneouS Coronary intErventions in Patients Treated With Oral Anticoagulant Therapy

Role: lead

NCT03445273Unknown

Maintenance Of aNtiplatElet Therapy in Patients With Coronary Stenting Undergoing Surgery

Role: lead

NCT02748603Unknown

Appropriateness of Coronary Angioplasty in PAtients With isCHEmic Heart Disease

Role: lead

NCT01433627Phase 3Unknown

Minimizing Adverse Haemorrhagic Events by TRansradial Access Site and Systemic Implementation of angioX

Role: lead

NCT01477775Phase 4Unknown

Customized Choice of Oral P2Y12 Receptor Blocker

Role: lead

NCT01377207Phase 4Completed

Optical Coherence Tomography Assessment of Gender diVersity In Primary Angioplasty. The OCTAVIA Trial

Role: lead

All 8 trials loaded